Le KD, et al. - Experts compared the cost-effectiveness of a freeze-only strategy from a patient perspective vs fresh embryo transfer (ET) after one completed in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycle in women without polycystic ovary syndrome (PCOS). The direct medical costs relating to treatment (cryopreservation, pregnancy follow-up, delivery), direct non-medical costs (travel, accommodation) and indirect costs (income lost) were measured for all patients. For non-PCOS women undergoing IVF/ICSI, researchers found there was a low probability of the freeze-only strategy being cost-effective vs fresh ET strategy.